2026 Microscope Slides and Coverslip Industry: Technological Innovation Empowers Dual Momentum in Domestic Substitution and High-End Upgrades

With the continuous expansion of the medical pathology diagnostics, scientific research innovation, and in vitro diagnostics industries, microscope slides and coverslips—core categories of basic experimental consumables—are entering a golden period of industry development. Since 2026, driven by policy guidance, technological breakthroughs, and market demand, the sector has exhibited distinct characteristics such as accelerated domestic substitution, product structure upgrades, and expanded application scenarios, becoming one of the most robust growth tracks in the medical device sub-sector.

The market size has been steadily rising, with significant achievements in domestic substitution. According to industry research reports, by 2025, China's microscope slide and coverslip industry had reached a market size of 1.28 billion yuan, marking a 6.7% year-on-year growth. The market size is projected to exceed 1.37 billion yuan in 2026, with the growth rate increasing to 7.0%, demonstrating sustained momentum. From a market structure perspective, medical-grade products remain the core pillar, accounting for 63.4% of the total, with a scale of approximately 811 million yuan. This growth is primarily driven by the National Medical Products Administration's standardized advancement in the filing management of pathological consumables and the increase in standardized pathology department coverage in top-tier hospitals to 92.7%. Research-grade products account for 36.6% of the market, primarily used in life sciences research at universities and research institutes, where stricter requirements for optical performance and dimensional accuracy make them a high-margin core segment of the industry.

Notably, the market competitiveness of domestic glass slides and coverslips continues to improve, while import dependency declines. In 2025, domestic products accounted for 71.7% of the domestic market, a decrease of 10.8 percentage points from 2021. Among them, domestic glass slides achieved a 78.3% win rate in centralized procurement for tertiary hospitals, up 12.1 percentage points from 2024. Leading enterprises such as Zhejiang Kandeley, Shandong Weigao, and Jiangsu Yuyue have upgraded GMP clean workshops and achieved full ISO13485 certification, meeting international standards for key parameters like thickness tolerance (±0.02mm) and surface particle count (≤3/100mm²). Together, these companies hold 41.6% of the domestic medical glass slide market share, with industry concentration steadily rising. The CR5 market share increased from 34.2% in 2023 to 49.8% in 2025. Meanwhile, domestic product exports performed exceptionally well, reaching 192 million yuan in 2025—a 11.4% year-on-year growth—primarily directed to emerging medical markets in Southeast Asia, the Middle East, and Africa, demonstrating the stable output capabilities of domestic medical consumables in terms of cost performance and compliance certifications.

Technological innovations continue to break through, driving product upgrades toward higher-end and more functional capabilities. The pain points of traditional glass slides and coverslips—such as low efficiency, unstable quality, and environmental hazards—are being gradually addressed through technological advancements. In the field of coverslips, the advent of pre-coated adhesive coverslips has achieved a leap from "experience-driven" to "standard-driven" in the mounting process. Utilizing innovative surface treatment techniques, the pre-applied solid mounting adhesive can rapidly cure upon activation, eliminating the need for traditional xylene-based mounting adhesives. This not only safeguards operator health but also prevents issues like bubbles and adhesive overflow. With heating and curing requiring only 5-10 minutes, it significantly enhances pathology sample preparation efficiency while precisely controlling adhesive volume to reduce material waste. In the glass slide sector, high-end functional products have emerged as a new growth engine, with surging demand for specialized slides such as ultra-thin (0.13–0.16mm) types, anti-detachment coatings, and conductive films. By 2025, shipments of high-end customized products are projected to grow by 28.6% year-on-year. Companies like ibidi have introduced µ-Slide tissue engineering microfluidic glass slides, which are tailored for advanced research applications like tissue engineering and organ-on-a-chip systems. These slides can create 3D biomimetic microenvironments, enable precise fluid control, and meet the demands of high-resolution microscopic imaging, propelling scientific research toward more refined and intelligent experimentation.

The upgrade of supporting technologies has also injected new vitality into industry development. Jinquan Medical's cold light source glass slide laser marking machine employs a non-contact marking technology, eliminating the need for consumables. It delivers clear and scratch-resistant printing results, seamlessly integrates with hospital HIS and PACS systems, and meets the demands of large-scale, intelligent slide production. It has consistently ranked first in domestic market installations for five consecutive years, capturing over 25% of the market share. Additionally, technological innovations in coverslip carriers have addressed industry pain points. The inclined base design prevents coverslip adhesion, while photoelectric detection holes provide consumable stock alerts, enhancing the smoothness of automated operations and boosting laboratory efficiency.

Policy support and demand expansion ensure a promising development outlook for the industry. At the national level, sustained efforts have been made to strengthen support for basic medical devices and scientific research consumables. In 2025, the National Medical Products Administration will officially include glass slides and coverslips in the dynamic adjustment list of the "Second-Class Medical Device Product Classification Catalog," clarifying their regulatory standards and driving the compliance product procurement rate in secondary and tertiary hospitals to rise to 83.6%. From the demand side, the annual sample volume for nationwide pathological diagnosis has exceeded 210 million cases, with clinical necessities alone supporting approximately 357 million glass slides consumed yearly. Additionally, the estimated installation of over 8,000 AI-assisted pathological diagnosis systems will drive a 9.2% annual increase in slide preparation, further stimulating market demand. Meanwhile, the widespread adoption of new technologies such as single-cell sequencing and spatial transcriptomics, along with the advancement of green pathology concepts, will continue to propel glass slides and coverslips toward environmentally friendly, high-precision, and customized development.

Industry insiders say that 2026 will be a crucial year for the high-quality development of the microscope slide and cover glass industry. Policy dividends, technological innovations, and market demand will form a synergy to promote the industry's transformation from "scale growth" to "quality improvement". In the future, high-quality enterprises with material and process accumulation, registration and application capabilities, and channel depth will seize the opportunity in the wave of domestic substitution and high-end upgrading. At the same time, with the regional reconstruction of the global laboratory consumables supply chain, the export potential of domestic glass slides and coverslips will be further released, promoting the sustainable and healthy development of the industry.